SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Haugland who wrote (815)12/21/1998 4:40:00 PM
From: Steve Lokness  Read Replies (1) of 1728
 
Thanks Richard;

Any other information you are able to provide to help understand these different chips and how they might be beneficial to the success to AFFX or GLGC or others will be greatly appreciated.

You are correct that the GLGC P/E is around one which is interesting enough on its own, but also suggest that the big money players are very interested in something that GLGC has to offer. While I believe most of this is from agreements it still gives some validity to their science.

ONC was indeed picked up by GLGC and I believe is responsible for the soft stock price. It may have been ONC's tissue database and perhaps patents that GLGC wanted. I thought the buyout made a lot of sense but it has been hard on share price.

I understand that the GLGC chip design is different from the AFFX chip and that each may have their advantages, however I also very interested in what is going on the chip. Is there not a very fast growing probe business tied to these chips?

Thanks;

Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News